Empagliflozin in Adults with Chronic Kidney Disease (CKD): Current Evidence and Place in Therapy

Empagliflozin in Adults with Chronic Kidney Disease (CKD): Current Evidence and Place in Therapy

Gates B Colbert,1 Hector M Madariaga,2 Anna Gaddy,3 Mohamed E Elrggal,4 Edgar V Lerma5 1Texas A&M University College of Medicine at Dallas, Dallas, TX, USA; 2Department of Internal Medicine, Lahey Hospital & Medical Center, Burlington, MA, USA; 3Department of Internal Medicine, Medical Colle...

Full description

Bibliographic Details
Main Authors: Colbert GB, Madariaga HM, Gaddy A, Elrggal ME, Lerma EV
Format: Article
Language:English
Published: Dove Medical Press 2023-02-01
Series:Therapeutics and Clinical Risk Management
Subjects:
empagliflozin
sglt2
chronic kidney disease
cardiovascular disease
diabetes
end stage kidney disease
Online Access:https://www.dovepress.com/empagliflozin-in-adults-with-chronic-kidney-disease-ckd-current-eviden-peer-reviewed-fulltext-article-TCRM

Internet

https://www.dovepress.com/empagliflozin-in-adults-with-chronic-kidney-disease-ckd-current-eviden-peer-reviewed-fulltext-article-TCRM

Similar Items